Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Experimental & Clinical Cancer Research : CR|July 18, 2023
Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasionCorinna Kosnopfel, Simone Wendlinger, Heike Niessner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2017
BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant MelanomaHeike Niessner, Tobias Sinnberg, Corinna Kosnopfel, et al.
Antioxidants (Basel, Switzerland)|August 26, 2022
Vitamin C Deficiency in Blood Samples of COVID-19 PatientsTobias Sinnberg, Christa Lichtensteiger, Katharina Hill-Mündel, et al.
British Journal of Cancer|April 9, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarkerElena Sophia Lindner, Jakob Admard, German Demidov, et al.
Frontiers in Oncology|March 18, 2021
Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant MelanomaAndrea Forschner, Tobias Sinnberg, Gabi Mroz, et al.
The Journal of Investigative Dermatology|October 15, 2010
The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cellsHeike Niessner, Daniela Beck, Tobias Sinnberg, et al.
International Journal of Cancer|December 11, 2023
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanismsLisa Dinter, Paula C Karitzky, Alexander Schulz, et al.
Ebiomedicine|June 9, 2023
Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastasesEftychia Chatziioannou, Jana Roßner, Thazin New Aung, et al.
Cancer Medicine|October 18, 2013
Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastasesHeike Niessner, Andrea Forschner, Bernhard Klumpp, et al.
Journal for Immunotherapy of Cancer|December 22, 2021
Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapyJonas Bochem, Henning Zelba, Janine Spreuer, et al.
Pageof 6